Stockholders' (Deficiency) Equity - Restricted Stock Units and Performance Restricted Stock Units - Activity (Details) - $ / shares |
12 Months Ended | |
---|---|---|
Mar. 31, 2022 |
Mar. 31, 2021 |
|
Shares | ||
Nonvested, balance at the beginning of the period (in shares) | 497,281 | |
Granted (in shares) | 328,963 | |
Vested and issued (in shares) | (194,444) | |
Forfeited (in shares) | (39,995) | |
Nonvested, balance at the end of the period (in shares) | 591,805 | 497,281 |
Awards expected to vest (in shares) | 591,805 | |
Weighted Average Grant-Date Fair Value | ||
Nonvested restricted stock units outstanding at the beginning of the period (in dollars per share) | $ 5.65 | |
Granted (in dollars per share) | 5.40 | |
Vested and issued (in dollars per share) | 5.18 | |
Forfeited (in dollars per share) | 5.78 | |
Nonvested restricted stock units outstanding at the end of the period (in dollars per share) | 5.66 | $ 5.65 |
Awards expected to vest (in dollars per share) | 5.66 | |
Restricted stock units | ||
Weighted Average Grant-Date Fair Value | ||
Granted (in dollars per share) | $ 5.40 | $ 5.28 |
X | ||||||||||
- Definition As of the balance sheet date, the number of shares into which equity instruments other than options expected to vest and outstanding can be converted under the equity-based compensation plan. No definition available.
|
X | ||||||||||
- Definition As of the balance sheet date, the weighted-average grant date fair value for outstanding equity awards expected to vest, other than options. No definition available.
|
X | ||||||||||
- Definition The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period. No definition available.
|
X | ||||||||||
- Definition Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Details
|